Leflutrozole for low testosterone and low sperm count
Part of Hormones & metabolism clinical trials.
This trial tests a new drug called Leflutrozole to see if it can improve testicular function in men with low testosterone and low sperm count. The goal is to help increase natural hormone levels and sperm production.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Men between 18 and 49 years old
- Low testosterone confirmed on two separate tests
- Estrogen (estradiol) level normal or high
- Luteinizing hormone (LH) level normal or low
- Low total motile sperm count in two samples
- Semen volume at least 1.0 mL in two samples
- Able to understand and follow the trial procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new hormone medication called leflutrozole can help men with azoospermia (no sperm in semen) produce sperm again. The medication works by adjusting hormone levels to stimulate sperm production.
This trial tests if a supplement made from Tribulus Terrestris (a plant) can help men with low sperm count (oligospermia) improve their fertility. It may be an option for men who are considering hormone treatments.
This trial tests whether hormone injections can help men with low testosterone and low sperm counts due to unknown causes. The goal is to restore healthy testosterone levels and improve fertility without surgery.
This study tests if an herbal supplement can improve sperm health in men with infertility. If you have low sperm count or poor sperm movement, this trial may help find a natural option to improve your chances of fathering a child.
This study tests two medicines—isotretinoin and human chorionic gonadotropin (hCG)—to see if they can improve sperm production in men with low sperm counts or no sperm due to certain causes. It might help if you haven't responded to other treatments before.
This trial tests a combination of high-dose testosterone with enzalutamide and difluoromethylornithine (DFMO) for men whose prostate cancer has spread and stopped responding to standard hormone therapy. It aims to see if this approach can shrink tumors or slow the cancer's growth.
Hear when a new Semen Quality trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.